Last reviewed · How we verify
CS19 expressing ETEC strain — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
CS19 expressing ETEC strain (CS19 expressing ETEC strain) — Johns Hopkins Bloomberg School of Public Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CS19 expressing ETEC strain TARGET | CS19 expressing ETEC strain | Johns Hopkins Bloomberg School of Public Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CS19 expressing ETEC strain CI watch — RSS
- CS19 expressing ETEC strain CI watch — Atom
- CS19 expressing ETEC strain CI watch — JSON
- CS19 expressing ETEC strain alone — RSS
Cite this brief
Drug Landscape (2026). CS19 expressing ETEC strain — Competitive Intelligence Brief. https://druglandscape.com/ci/cs19-expressing-etec-strain. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing